FindTrial
Sign In

A Randomised Double-blind Placebo-controlled Trial of Prophylactic Antibiotics in Preventing Female Urinary Tract Infection After Urodynamic Study

A Randomised Double-blind Placebo-controlled Trial of Prophylactic Antibiotics in Preventing Female Urinary Tract Infection After Urodynamic Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-05000737
Enrollment
Unknown
Registered
2005-12-15
Start date
2005-10-17
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Tract Infection

Interventions

1:Augmentin 375mg (single oral dose) in 15 min
2:Placebo 1 tab

Sponsors

N.A.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All women requiring urodynamic studies attending the Urodynamic Clinic at Prince of Wales Hospital will be explained about the study and will be recruited.

Exclusion criteria

Exclusion criteria: (1) evidence of UTI at the time of UDS; (2) receiving antibiotics treatment; (3) had received antibiotics treatments two weeks before UDS; (4) requiring prophylactic antibiotics for invasive procedures; (5) allergic to antibiotics; (6) possible drug-drug interaction, and (7) refusal to participate.

Design outcomes

Primary

MeasureTime frame
This project will answer the clinical question of whether prophylactic antibiotic is useful in preventing UTI in women undergoing UDS. This will change the clinical practice in managing such patients in Hong Kong, whom at the present moment have high prevalence of post-UDS UTI.;—

Countries

China

Contacts

Public ContactProf. Yip Shing-Kai
yipsk@cuhk.edu.hkNil

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026